Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | B. Braun Medical | N-202106 RX | 2015-04-30 | 2 products |
MEROPENEM | HQ Specialty Pharma | N-215212 RX | 2023-07-26 | 1 products, RLD, RS |
MERREM | Mylan | N-050706 RX | 1996-06-21 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VABOMERE | REMPEX | N-209776 RX | 2017-08-29 | 1 products, RLD, RS |
Expiration | Code | ||
---|---|---|---|
MEROPENEM / VABORBACTAM, VABOMERE, REMPEX | |||
2027-08-29 | GAIN | ||
2022-08-29 | NCE |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sepsis | D018805 | HP_0100806 | A41.9 | 1 | 4 | 6 | 5 | 11 | 23 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | 1 | 2 | 11 | 2 | 1 | 17 |
Infections | D007239 | EFO_0000544 | — | 1 | 2 | 3 | 3 | 6 | 14 |
Pneumonia | D011014 | EFO_0003106 | — | — | 1 | 4 | 2 | 6 | 13 |
Ventilator-associated pneumonia | D053717 | EFO_1001865 | J95.851 | — | 1 | 10 | 2 | 1 | 13 |
Bacterial infections | D001424 | — | A49 | 5 | 1 | 1 | 3 | 4 | 13 |
Intraabdominal infections | D059413 | — | — | 1 | 5 | 6 | 1 | — | 12 |
Septic shock | D012772 | — | A48.3 | 3 | 3 | 3 | 2 | 4 | 12 |
Critical illness | D016638 | — | — | — | 1 | — | 1 | 9 | 11 |
Pyelonephritis | D011704 | EFO_1001141 | N10-N16 | — | 2 | 8 | 1 | — | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Appendicitis | D001064 | EFO_0007149 | K37 | — | — | 2 | — | 1 | 3 |
Sinusitis | D012852 | EFO_0007486 | J32 | — | — | 1 | — | 1 | 2 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | 1 | — | 1 | 2 |
Neonatal sepsis | D000071074 | HP_0040187 | — | — | — | 1 | — | 1 | 2 |
Bacterial pneumonia | D018410 | EFO_1001272 | J15.9 | — | 1 | 1 | — | — | 2 |
Peritonitis | D010538 | EFO_0008588 | K65 | — | — | 1 | — | 1 | 2 |
Ascites | D001201 | HP_0001541 | R18 | — | 1 | 1 | — | — | 1 |
Iatrogenic disease | D007049 | — | — | — | — | 1 | — | — | 1 |
Lung diseases | D008171 | HP_0002088 | J98.4 | — | — | 1 | — | — | 1 |
Abscess | D000038 | EFO_0003030 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pulmonary tuberculosis | D014397 | EFO_1000049 | A15 | — | 3 | — | — | — | 3 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | 1 | 1 | — | — | — | 2 |
Melioidosis | D008554 | — | A24.9 | — | 1 | — | — | 1 | 2 |
Cross infection | D003428 | — | — | — | 1 | — | — | 1 | 2 |
Communicable diseases | D003141 | — | — | — | 1 | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | 1 | — | — | — | 1 |
Systemic inflammatory response syndrome | D018746 | EFO_1001478 | R65.10 | — | 1 | — | — | — | 1 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 1 | — | — | — | 1 |
Respiratory insufficiency | D012131 | HP_0002093 | J96.9 | 1 | 1 | — | — | — | 1 |
Meningitis | D008581 | HP_0001287 | G03 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Inflammation | D007249 | MP_0001845 | — | 1 | — | — | — | — | 1 |
Osteoporosis | D010024 | HP_0000939 | M81.0 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | — | — | — | — | 6 | 6 |
Acute kidney injury | D058186 | HP_0001919 | N17 | — | — | — | — | 4 | 4 |
Drug monitoring | D016903 | — | — | — | — | — | — | 3 | 3 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | — | 2 | 2 |
Renal replacement therapy | D017582 | — | — | — | — | — | — | 2 | 2 |
Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | — | 1 | 1 |
Heart failure | D006333 | HP_0001635 | I50 | — | — | — | — | 1 | 1 |
Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 1 | 1 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | — | — | 1 | 1 |
Drug common name | Meropenem |
INN | meropenem |
Description | Meropenem is a carbapenemcarboxylic acid in which the azetidine and pyrroline rings carry 1-hydroxymethyl and in which the azetidine and pyrroline rings carry 1-hydroxymethyl and 5-(dimethylcarbamoyl)pyrrolidin-3-ylthio substituents respectively. It has a role as an antibacterial drug, an antibacterial agent and a drug allergen. It is a carbapenemcarboxylic acid, a pyrrolidinecarboxamide, an alpha,beta-unsaturated monocarboxylic acid and an organic sulfide. |
Classification | Small molecule |
Drug class | antibacterial antibiotics, carbapenem derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12 |
PDB | — |
CAS-ID | 96036-03-2 |
RxCUI | — |
ChEMBL ID | CHEMBL127 |
ChEBI ID | 43968 |
PubChem CID | 441130 |
DrugBank | DB00760 |
UNII ID | YOP6PX0BAO (ChemIDplus, GSRS) |